850 filings
Page 3 of 43
8-K
n1fcx 0prd77my29sfht
21 May 20
Navidea Biopharmaceuticals Announces Positive Results of Second Interim Analysis of Ongoing Phase 2B Study in Rheumatoid Arthritis
5:25pm
S-8
1vfvts6hx4jbqxqi
18 May 20
Registration of securities for employees
12:00am
8-K
81k mpci0tphosrrap11
14 May 20
Navidea Biopharmaceuticals Reports First Quarter 2020 Financial Results
4:09pm
8-K
q2y7fdu0cjkglp4kv1d
12 May 20
Entry into a Material Definitive Agreement
4:52pm
8-K
qs7gsqacc70fn1bp
11 Mar 20
Navidea Biopharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results
4:09pm
SC 13D/A
ue9qiuka odgyj18
26 Feb 20
Navidea Biopharmaceuticals, Inc.
4:35pm
4
vtqxiiq
20 Feb 20
NAVIDEA BIOPHARMACEUTICALS / Jed Latkin ownership change
4:39pm
4
1ulgeku
19 Feb 20
NAVIDEA BIOPHARMACEUTICALS / John K Jr. Scott ownership change
3:58pm
8-K
d496jd
18 Feb 20
Entry into a Material Definitive Agreement
5:30pm
424B5
73ze4sa1a6kva
18 Feb 20
Prospectus supplement for primary offering
5:29pm
8-K
renbujcqvroz9o x9f
14 Feb 20
Entry into a Material Definitive Agreement
12:02pm
4
bncj61mwjkfpd92r
7 Feb 20
NAVIDEA BIOPHARMACEUTICALS / Michael Stanley Rosol ownership change
4:17pm
4
johtu1eme48mzpf843
7 Feb 20
NAVIDEA BIOPHARMACEUTICALS / Jed Latkin ownership change
4:15pm
4
7hg7d
7 Feb 20
NAVIDEA BIOPHARMACEUTICALS / Sarah Kathryn Rouan ownership change
4:13pm
4
x2cq9 uml2fs7h9j
7 Feb 20
NAVIDEA BIOPHARMACEUTICALS / YEHUDA MICHAEL RICE ownership change
4:12pm
4
z4p56yq8
7 Feb 20
NAVIDEA BIOPHARMACEUTICALS / Adam D. Cutler ownership change
4:10pm
4
0osec8n6e zk4mvyjun
7 Feb 20
NAVIDEA BIOPHARMACEUTICALS / Claudine Bruck ownership change
4:09pm
EFFECT
p1c 39k0c
10 Jan 20
Notice of effectiveness
12:15am